Background: Early diagnosis of a brain tumor may increase life expectancy. Magnetic resonance imaging (MRI) accompanied by several segmentation algorithms is preferred as a reliable method for assessment. The availability of high-dimensional medical image data during diagnosis places a heavy computational burden and a suitable pre-processing step is required for lower- dimensional representation. The storage requirement and complexity of image data are also a concern. To address this concern, the random projection technique (RPT) is widely used as a multivariate approach for data reduction.
Aim: This study mainly focuses on T1-weighted MRI image clustering for brain tumor segmentation with dimension reduction by using the conventional principal component analysis (PCA) and RPT.
Methods: Two clustering algorithms, K-means and fuzzy c-means (FCM) were used for brain tumor detection. The primary study objective was to present a comparison of the two clustering methods between MRI images subjected to PCA and RPT. In addition to the original dimension of 512 × 512, three other image sizes, 256 × 256, 128 × 128, and 64 × 64, were used to determine the effect of the methods.
Results: In terms of average reconstruction, Euclidean distance, and segmentation distance errors, the RPT produced better results than the PCA method for all the clustered images from clustering techniques.
Conclusion: According to the values of performance metrics, RPT supported fuzzy c-means in achieving the best clustering performance and provided significant results for each new size of the MRI images.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.2174/1573405616666200712180521 | DOI Listing |
Pharmacol Res
January 2025
Department of Physiology, Tongji Medical College of Huazhong University of Science & Technology, Wuhan, 430030, PR China. Electronic address:
Pediatric high-grade gliomas (pHGGs) are the most common brain malignancies in children and are characterized by blocked differentiation. The epigenetic landscape of pHGGs, particularly the H3K27-altered and H3G34-mutant subtypes, suggests these tumors may be particularly susceptible to strategies that target blocked differentiation. Differentiation therapy aims to overcome this differentiation blockade by promoting glioma cell differentiation into more mature and less malignant cells.
View Article and Find Full Text PDFCurr Med Chem
January 2025
Shree S. K. Patel College of Pharmaceutical Education and Research, Ganpat University, Kherva, 384012, India.
Aims: This study aimed to develop Imatinib Mesylate (IMT)-loaded Poly Lactic-co-Glycolic Acid (PLGA)-D-α-tocopheryl polyethylene glycol succinate (TPGS)- Polyethylene glycol (PEG) hybrid nanoparticles (CSLHNPs) with optimized physicochemical properties for targeted delivery to glioblastoma multiforme.
Background: Glioblastoma multiforme (GBM) is the most destructive type of brain tumor with several complications. Currently, most treatments for drug delivery for this disease face challenges due to the poor blood-brain barrier (BBB) and lack of site-specific delivery.
Transl Cancer Res
December 2024
BGI Research, Chongqing, China.
Background: Medulloblastoma (MB) is a highly malignant childhood brain tumor. Previous research on the genetic underpinnings of MB subtypes has predominantly focused on European and American cohorts. Given the notable genetic differences between Asian and other populations, a subtype-specific study on an Asian cohort is essential to provide comprehensive insights into MB within this demographic.
View Article and Find Full Text PDFTransl Cancer Res
December 2024
Department of Radiation Oncology, The Second Hospital of Lanzhou University, Lanzhou, China.
Background: Within the realm of primary brain tumors, specifically glioblastoma (GBM), presents a notable obstacle due to their unfavorable prognosis and differing median survival rates contingent upon tumor grade and subtype. Despite a plethora of research connecting cardiotrophin-1 (CTF1) modifications to a range of illnesses, its correlation with glioma remains uncertain. This study investigated the clinical value of CTF1 in glioma and its potential as a biomarker of the disease.
View Article and Find Full Text PDFHeliyon
January 2025
Children's Brain Tumour Research Centre, School of Medicine, Biodiscovery Institute, University of Nottingham, UK.
Isocitrate dehydrogenase wild-type glioblastoma (GBM) is characterised by a heterogeneous genetic landscape resulting from dynamic competition between tumour subclones to survive selective pressures. Improvements in metabolite identification and metabolome coverage have led to increased interest in clinically relevant applications of metabolomics. Here, we use liquid chromatography-mass spectrometry and gene expression microarray to profile integrated intratumour metabolic heterogeneity, as a direct functional readout of adaptive responses of subclones to the tumour microenvironment.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!